Cargando…
OCT parameters in patients with diabetic maculopathy
The treatment of the clinically significant macular edema in patients with diabetic maculopathy by the intravitreal administration of corticosteroids and antiangiogenic factors requires rapid and more accurate investigation methods aimed at following up the dynamic evolution of the structural parame...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391348/ https://www.ncbi.nlm.nih.gov/pubmed/25870665 |
_version_ | 1782365811909853184 |
---|---|
author | Serban, R Cioboata, M Chiotan, C Cornăcel, C Liora, R Anghelie, A |
author_facet | Serban, R Cioboata, M Chiotan, C Cornăcel, C Liora, R Anghelie, A |
author_sort | Serban, R |
collection | PubMed |
description | The treatment of the clinically significant macular edema in patients with diabetic maculopathy by the intravitreal administration of corticosteroids and antiangiogenic factors requires rapid and more accurate investigation methods aimed at following up the dynamic evolution of the structural parameters of the retina. The purpose of the study is to compare the outcome of OCT parameters for each group (Group A treated by intravitreal administered triamcinolone acetonide and Group B treated by intravitreal administered triamcinolone acetonide in combination with bevacizumab). Methods involved the selection of cases, dynamic measurements of the retina structures, so that, at the end, the data from the two groups of patients could be compared. The results showed a positive development in the short and medium term in both groups of patients. Abbreviations: OCT = optical coherence tomography, WESDR = epidemiological study of diabetic retinopathy Wisconsin, ETDRS = study early treatment of diabetic retinopathy, retinal thickness GRC = central-VMT total macular volume, VEGF, vascular endothelial growth factor |
format | Online Article Text |
id | pubmed-4391348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43913482015-04-13 OCT parameters in patients with diabetic maculopathy Serban, R Cioboata, M Chiotan, C Cornăcel, C Liora, R Anghelie, A J Med Life Reviews The treatment of the clinically significant macular edema in patients with diabetic maculopathy by the intravitreal administration of corticosteroids and antiangiogenic factors requires rapid and more accurate investigation methods aimed at following up the dynamic evolution of the structural parameters of the retina. The purpose of the study is to compare the outcome of OCT parameters for each group (Group A treated by intravitreal administered triamcinolone acetonide and Group B treated by intravitreal administered triamcinolone acetonide in combination with bevacizumab). Methods involved the selection of cases, dynamic measurements of the retina structures, so that, at the end, the data from the two groups of patients could be compared. The results showed a positive development in the short and medium term in both groups of patients. Abbreviations: OCT = optical coherence tomography, WESDR = epidemiological study of diabetic retinopathy Wisconsin, ETDRS = study early treatment of diabetic retinopathy, retinal thickness GRC = central-VMT total macular volume, VEGF, vascular endothelial growth factor Carol Davila University Press 2014 /pmc/articles/PMC4391348/ /pubmed/25870665 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Serban, R Cioboata, M Chiotan, C Cornăcel, C Liora, R Anghelie, A OCT parameters in patients with diabetic maculopathy |
title | OCT parameters in patients with diabetic maculopathy |
title_full | OCT parameters in patients with diabetic maculopathy |
title_fullStr | OCT parameters in patients with diabetic maculopathy |
title_full_unstemmed | OCT parameters in patients with diabetic maculopathy |
title_short | OCT parameters in patients with diabetic maculopathy |
title_sort | oct parameters in patients with diabetic maculopathy |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391348/ https://www.ncbi.nlm.nih.gov/pubmed/25870665 |
work_keys_str_mv | AT serbanr octparametersinpatientswithdiabeticmaculopathy AT cioboatam octparametersinpatientswithdiabeticmaculopathy AT chiotanc octparametersinpatientswithdiabeticmaculopathy AT cornacelc octparametersinpatientswithdiabeticmaculopathy AT liorar octparametersinpatientswithdiabeticmaculopathy AT angheliea octparametersinpatientswithdiabeticmaculopathy |